Rocket Pharmaceuticals Inc (RCKT) Stock Price, Quote & News

Company Profile

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States. It develops vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inher...

Industry: Biotechnology

Sector: Healthcare

Phone: 609 659 8001

Website: www.rocketpharma.com

Address:

9 Cedarbrook Drive, Cranbury, United States

Newtimmy Aug. 5 at 12:15 AM

$RCKT I may have missed it, but is an earnings release date set?

1 · Reply

Teo_j Aug. 4 at 10:14 PM

$RCKT some massive orders happened after close immediately did any one so that

2 · Reply

jjmo1491 Aug. 4 at 6:42 PM

$PLRX im out of here, this will probably keep going up over next couple weeks though! $ADVM $RCKT here we come

0 · Reply

AnalyticaInvestor Aug. 4 at 10:50 AM

$SLP $RCKT $PEPG $QMCO 🧬 Biotech & Tech Bounceback? $SLP, $PEPG, $RCKT all down 50–75%+ YTD but showing signs of life. From AI-driven drug discovery to gene therapy breakthroughs, these high-risk plays are drawing fresh attention. $QMCO popped 10% despite an –86% YTD collapse, reminding investors that small caps can move fast in both directions. Catching a falling knife or finding deep value? 📊 Read the full Analytica Investor for all the insights 👇 https://analyticainvestor.beehiiv.com/p/you-re-fired-3502b8c8dd61d73c

1 · Reply

Chickenforyou Aug. 4 at 2:19 AM

$RCKT news soon?

0 · Reply

DinoMcnuggets Aug. 1 at 4:33 PM

$RCKT Wrote 2.5$ puts here for august 15th. 5 cents of premium. 2.5% return for 14 day hold. Very low risk. Assigned at 2.45$ per share which is a very good price

1 · Reply

p0ppycampbell Aug. 1 at 3:30 PM

$SRPT $CAPR $SLS $REPL $RCKT Wrong! Here's proof us Capricor short sellers bought shares with the put profits we made. We keep loading SRPT shares and don't listen to bears. @WBinthehouse is just a Capricor investor who hasn't realized CAPR is a scam and SRPT are the only ones who have a real DMD drug and years of knowledge.

3 · Reply

pjapak Aug. 1 at 2:24 PM

$RCKT Usually ERs are bland here with repeatation of known information. Fireworks will be after ER. Waiting for insiders to buy.

1 · Reply

Jabed206 Jul. 31 at 8:20 PM

$RCKT srpt had it hold lifted yet this tickers hold will continue until infinity..

1 · Reply

xXCronoSXx Jul. 30 at 4:50 PM

$RCKT

0 · Reply

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 30, 2025, 11:07 AM EDT - 6 days ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA QURE

Jul 29, 2025, 10:26 AM EDT - 7 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 25, 2025, 3:02 PM EDT - 11 days ago

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

Jul 24, 2025, 4:02 PM EDT - 12 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Jul 24, 2025, 7:00 AM EDT - 12 days ago

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Jul 17, 2025, 7:00 AM EDT - 19 days ago

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

Jul 11, 2025, 10:25 AM EDT - 25 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 9, 2025, 5:16 PM EDT - 27 days ago

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

Jul 7, 2025, 9:00 AM EDT - 4 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Jun 30, 2025, 7:00 AM EDT - 5 weeks ago

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

Jun 12, 2025, 10:00 AM EDT - 7 weeks ago

Rocket Pharmaceuticals, Inc. (RCKT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 11, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Shareholders to Inquire about Securities Investigation

Jun 10, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Shareholders to Connect

Jun 9, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Shareholders to Reach Out

Jun 8, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Rocket Pharmaceuticals, Inc. (RCKT) and Encourages Investors to Learn More About the Investigation

Jun 6, 2025, 10:00 AM EDT - 2 months ago

Rocket Pharmaceuticals, Inc. (RCKT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 5, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Connect

Newtimmy Aug. 5 at 12:15 AM

$RCKT I may have missed it, but is an earnings release date set?

1 · Reply

Teo_j Aug. 4 at 10:14 PM

$RCKT some massive orders happened after close immediately did any one so that

2 · Reply

jjmo1491 Aug. 4 at 6:42 PM

$PLRX im out of here, this will probably keep going up over next couple weeks though! $ADVM $RCKT here we come

0 · Reply

AnalyticaInvestor Aug. 4 at 10:50 AM

1 · Reply

Chickenforyou Aug. 4 at 2:19 AM

$RCKT news soon?

0 · Reply

DinoMcnuggets Aug. 1 at 4:33 PM

$RCKT Wrote 2.5$ puts here for august 15th. 5 cents of premium. 2.5% return for 14 day hold. Very low risk. Assigned at 2.45$ per share which is a very good price

1 · Reply

p0ppycampbell Aug. 1 at 3:30 PM

3 · Reply

pjapak Aug. 1 at 2:24 PM

$RCKT Usually ERs are bland here with repeatation of known information. Fireworks will be after ER. Waiting for insiders to buy.

1 · Reply

Jabed206 Jul. 31 at 8:20 PM

$RCKT srpt had it hold lifted yet this tickers hold will continue until infinity..

1 · Reply

xXCronoSXx Jul. 30 at 4:50 PM

$RCKT

0 · Reply

pjapak Jul. 29 at 6:51 PM

$RCKT This will be 12-18 by year end. Just searching the bottom.

1 · Reply

Jabed206 Jul. 29 at 12:09 PM

$RCKT how many more months to wait lol

1 · Reply

darntootin Jul. 28 at 10:06 PM

$RCKT Looks like the FDA is willing to work with gene therapy companies I would say Serepta Was a pretty good test of what’s to come the new head of CDER was very critical of the approval of Sereptas drug and put a hold on it due to a death well they lifted it tonight and boom big gains for investors I got a feeling Rocket will Be next 🤞🏻

1 · Reply

chezki Jul. 27 at 3:24 PM

$RCKT THE ROCKET IS CRASHING DOWN!!! JUMP OUT FAST!!

1 · Reply

Nierka1 Jul. 27 at 2:17 PM

$RCKT what we thinking guys.. dead money for a year or so.

0 · Reply

BioAB Jul. 26 at 1:19 AM

$CAPR $SRPT $RCKT - which of these would you buy? NFA, of course, just opinions.

2 · Reply

JarvisFlow Jul. 25 at 6:25 PM

Canaccord Genuity has adjusted their stance on Rocket Pharmaceuticals ( $RCKT ), setting the rating to Buy with a target price of 11 → 10.

0 · Reply

JarvisFlow Jul. 25 at 11:00 AM

B of A Securities has adjusted their stance on Rocket Pharmaceuticals ( $RCKT ), setting the rating to Neutral with a target price of 9 → 4.

0 · Reply

11thestate Jul. 25 at 5:27 AM

$RCKT stockholders filed a claim against Rocket Pharma for allegedly hiding fatal risks in its gene therapy trial and misleading investors about its Danon disease program. You can join this case to be notified about any new information: https://11th.com/cases/rocketpharma-investor-suit

0 · Reply

JarvisFlow Jul. 24 at 11:00 PM

Chardan Capital has adjusted their stance on Rocket Pharmaceuticals ( $RCKT ), setting the rating to Buy with a target price of 17 → 12.

0 · Reply

guidoschini Jul. 24 at 5:53 PM

$RCKT always worse

0 · Reply

Zooooo Jul. 24 at 2:48 PM

$SRPT $RCKT $REPL $CAPR Nice, cite all the riskiest possible therapies and act like this is a surprise. It’s ok to play, but accept loss. Don’t blame others

0 · Reply

Market Cap	327.83M
Revenue (ttm)	0.00
Net Income (ttm)	-258.75M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,126,200
Avg Vol	5,418,252
Day's Range	N/A - N/A
Shares Out	106.79M
Stochastic %K	19%
Beta	0.65
Analysts	Sell
Price Target	$8.37